CNS Stock Analysis: Buy, Sell, or Hold?
CNS - Cohen & Steers Inc.
$82.27
0.70 (0.86%)
▲
5d:
+1.13%
30d:
+6.28%
90d:
+17.04%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 15, 2026
Get Alerted When CNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CNS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CNS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$105.73
Based on 7.8% avg growth
INTRINSIC VALUE TODAY
$65.65
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNS is currently trading at $82.27, which is considered extended relative to its 30-day fair value range of $76.98 to $81.79. From a valuation perspective, the stock is trading at a premium (Forward PE: 21.1) compared to its historical average (18.7). At these levels, the market is pricing in 4.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNS is in a strong uptrend. The price is approaching resistance at $84.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $73.67. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNS is in a strong uptrend. The price is approaching resistance at $84.58. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $73.67. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$76.98 -
$81.79
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.4%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 10.5% above Wall St target ($73.67)
- NEUTRAL: Market pricing in 4.2% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$76.98 -
$81.79
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$78.87
Resistance Level
$84.59
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.15
Wall Street Target
$73.67
(-10.5%)
Revenue Growth (YoY)
12.2%
Earnings Growth (YoY)
31.9%
Profit Margin
28.8%
Valuation Premium vs History
+4.2% premium
PE vs Historical
21.2 vs 18.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.2%
(market-implied from PE analysis)
1-Year Target
$85.73
(+4%)
2-Year Target
$89.33
(+9%)
3-Year Target
$93.08
(+13%)
3-Yr Target (if PE normalizes)
(PE: 21→19)
PE COMPRESSION
$82.30
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.1, Growth: 11.6%)
$114.25
(+39%)
Base:
(SPY PE: 20.7, Growth: 11.6%)
$111.98
(+36%)
Bear:
(PE: 17.6, Growth: 11.6%)
$95.19
(+16%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 25.10 | Current EPS (TTM): $3.25
Bull Case
$107.40
(+31%)
Analyst growth 19.7%, PE expands to 27.6
Base Case
$97.63
(+19%)
Market implied 19.7%, PE stable at 25.1
Bear Case
$55.47
(-33%)
Severe decline -20.0%, PE contracts to 21.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 03, 2026 12:59 AM ET
Data refreshes hourly during market hours. Next update: 1:59 AM
Data refreshes hourly during market hours. Next update: 1:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Francis C Poli
SELL
10000 shares
2026-02-12
Francis C Poli
SELL
9696 shares
2026-02-11
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KKR
KKR & Co. Inc. |
STRONG BUY
21 analysts |
$126 | 60 HOLD |
|
BLK
BlackRock Inc |
STRONG BUY
17 analysts |
$1314 | 51 HOLD |
|
BX
Blackstone Group Inc |
HOLD
23 analysts |
$142 | 58 HOLD |
|
OWL
Blue Owl Capital Inc |
STRONG BUY
15 analysts |
$12 | 55 HOLD |
|
CRBG
Corebridge Financial Inc. |
STRONG BUY
14 analysts |
$38 | 53 HOLD |
